Skip to main content

letter

. 1995 Jul 8;311(6997):124–125. doi: 10.1136/bmj.311.6997.124a

Effect of alfacalcidol on renal bone disease in mild to moderate renal failure. Monitoring the calcium-phosphate product is important.

M S McGregor, P A Rowe, B J Junor

PMCID: PMC2550168 PMID: 7613376

124

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Hamdy N. A., Kanis J. A., Beneton M. N., Brown C. B., Juttmann J. R., Jordans J. G., Josse S., Meyrier A., Lins R. L., Fairey I. T. Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ. 1995 Feb 11;310(6976):358–363. doi: 10.1136/bmj.310.6976.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
Hebert L. A., Lemann J., Jr, Petersen J. R., Lennon E. J. Studies of the mechanism by which phosphate infusion lowers serum calcium concentration. J Clin Invest. 1966 Dec;45(12):1886–1894. doi: 10.1172/JCI105493. [DOI] [PMC free article] [PubMed] [Google Scholar]
Nichols P., Owen J. P., Ellis H. A., Farndon J. R., Kelly P. J., Ward M. K. Parathyroidectomy in chronic renal failure: a nine-year follow-up study. Q J Med. 1990 Nov;77(283):1175–1193. doi: 10.1093/qjmed/77.2.1175. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES